Clinical trial
Propofol Injection for Daily Headache
NCT00228267 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00228267 |
|---|---|
| Title | Propofol Injection for Daily Headache |
| Official title | The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial |
| Lead sponsor | University of Alberta, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Headache, Analgesic Rebound Headache, Chronic Daily Headache, Headache, Intractable |
| Intervention type | Drug |
| Interventions | Propofol |
| Enrollment | 28 |
| Start date | Sep 1, 2004 |
| Completion | Nov 1, 2007 |
| First posted | Sep 28, 2005 |
| Last update posted | May 4, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: